SCHEMBL10153386

SCHEMBL10153386

O=c1[nH]nc(C2CCCN2)[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 5/20 0.38
▸ CDC7 O00311 6/20 0.37
▸ CCNE1 P24864 3/20 0.37
▸ CDK2 P24941 3/20 0.37
▸ ROCK1 Q13464 3/20 0.37
▸ DBF4 Q9UBU7 3/20 0.37
▸ SCN10A Q9Y5Y9 1/20 0.36
▸ CHRNB2 P17787 1/20 0.36
▸ CHRNA7 P36544 1/20 0.36
▸ CHRNA4 P43681 1/20 0.36
▸ PIM1 P11309 3/20 0.36
▸ CSNK2B P67870 3/20 0.36
▸ CSNK2A1 P68400 3/20 0.36
▸ DYRK1A Q13627 2/20 0.36
▸ CIT O14578 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CSNK2A2 P19784 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ CSNK2A3 Q8NEV1 1/20 0.36
▸ TAOK3 Q9H2K8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16059650 0.71 HCAR2 (0.35) CYP1A2
SCHEMBL16060013 0.70 — —
SCHEMBL27906827 0.68 MAPT (0.40) PARP1CDC7CCNE1CDK2ROCK1
SCHEMBL12672828 0.67 CHRM2 (0.41) PARP1CDC7CCNE1CDK2ROCK1
SCHEMBL3830197 0.67 CHRNB2 (0.38) CHRNB2CHRNA7CHRNA4CYP1A2
SCHEMBL47075 0.67 CHRM2 (0.41) PARP1CDC7CCNE1CDK2ROCK1
SCHEMBL812418 0.67 CHRNB2 (0.37) PARP1SCN10ACHRNB2CHRNA7CHRNA4
SCHEMBL953414 0.67 CHRNB2 (0.37) PARP1SCN10ACHRNB2CHRNA7CHRNA4
SCHEMBL2994601 0.67 CHRNB2 (0.37) PARP1SCN10ACHRNB2CHRNA7CHRNA4
Hydrochloric Acid SCHEMBL3830581 0.66 CYP1A2 (0.38) CHRNB2CHRNA4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140275017-A1 CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2014-09-18 — — US disclosed
US-20140275017-A1 CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2014-09-18 — — US disclosed
US-8778957-B2 CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2014-07-15 — — US disclosed
US-8778957-B2 CGRP receptor antagonists MERCK SHARP & DOHME CORP. (US) 2014-07-15 — — US disclosed
US-20120010193-A1 CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2012-01-12 — — US disclosed
US-20120010193-A1 CGRP RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2012-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275017-A1 CGRP RECEPTOR ANTAGONISTS BDKRB1, CALCRL, BDKRB2 PARP1 2366/4885CDC7 3281/4885CCNE1 1514/4885
US-20120010193-A1 CGRP RECEPTOR ANTAGONISTS BDKRB1, BDKRB2, CALCRL PARP1 2384/4885CDC7 3238/4885CCNE1 1531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback